Orum Therapeutics Inc (475830) Stock Price & News

475830:KOSDAQ

Orum Therapeutics Inc

₩67,900.00

-4.50%

(-3,200.00) 1D

Jun 12, 3:30:29 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 475830...

Open

₩73,500

High

₩76,900

Low

₩67,100

Mkt. cap

1.46T

Avg. vol.

235.29K

Volume

0.00

52-wk high

₩146,600

52-wk low

₩16,930

EPS

-₩2,254

Shares outstanding

21.51M

No. of employees

Open

₩73,500

High

₩76,900

Low

₩67,100

Mkt. cap

1.46T

Avg. vol.

235.29K

Volume

0.00

52-wk high

₩146,600

52-wk low

₩16,930

EPS

-₩2,254

Shares outstanding

21.51M

No. of employees

Related stocks

141080

LigaChem Biosciences Inc

News stories

From sources across the web

Business Insider

1 hour ago

Mega-IPOs and inflation will sink the Nasdaq by 35%, top-rated fund manager says

Yahoo Finance

1 hour ago

Have S&P 500 Index Funds, Often Touted as the Best Stock Investments, Become Dangerous? There's a Worrisome Development -- and a Possibly Better Alternative.

Simply Wall Street

59 minutes ago

Did Record Backlog and New Interconnect Services Just Shift Equinix's (EQIX) Investment Narrative?

WBTW

22 hours ago

You can ignore AI giants like SpaceX, but your 401(k) won’t

About Orum Therapeutics Inc

CEO-

Employees21

Founded2016

Headquarters-

SectorBiotechnology

Websiteorumrx.com

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	4.16M	15.89M	558.17K	-
Cost of goods sold	257.00K	-	-	170.00K
Cost of revenue	257.00K	-	-	170.00K
Research and development expenses	6.22B	9.89B	13.98B	13.80B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.81B	3.39B	3.22B	3.26B
Operating expense	10.00B	13.95B	18.26B	18.08B
Total operating expenses	10.00B	13.95B	18.26B	18.08B
Operating income	-10.00B	-13.94B	-18.25B	-18.08B
Other non operating income	5.28B	-1.08M	34.77M	48.71M
EBT including unusual items	-3.77B	-13.62B	-18.16B	-15.28B
EBT excluding unusual items	-4.47B	-14.48B	-18.73B	-17.18B
Income tax expense	-	-	-2.18B	-
Effective tax rate	-	-	12.02%	-
Other operating expenses	58.42M	35.19M	87.88M	188.21M
Net income	-3.77B	-13.62B	-15.97B	-15.28B
Net profit margin	-90,619.71%	-85,717.86%	-2,862,010.66%	-
Earnings per share	-	-	-	-
Interest and investment income	243.32M	350.80M	226.55M	648.35M
Interest expense	-466.68M	-461.04M	-478.02M	-469.06M
Net interest expenses	-223.36M	-110.24M	-251.46M	179.30M
Depreciation and amortization charges	902.85M	646.77M	974.08M	831.64M
EBITDA	-9.09B	-13.29B	-17.28B	-17.24B
Gain or loss from assets sale	-66.12M	-	70.25M	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research